Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
    • Expanded Access: Insights & Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
    • Expanded Access: Insights & Resources
  • Expanded Access eRequest

Expanded Access Listings

You can search in free text – simply type the disease, drug, company name, or other detail into the Search bar below and click Apply
Displaying 460 of 493

Carcinex Inc

Fujian Haixi Pharmaceuticals Co., Ltd.

EA Page: https://www.hxpharma.com/article/294.html?lang=en

Conjupro Biotherapeutics Inc.

EA Page: https://conjuprobio.com/clinical-trials/

GI Innovation Inc.

EA Page: https://www.gi-innovation.com/en/

SOTIO Biotech

EA Page: https://sotio.com/pipeline/antibody-drug-conjugates/technology

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd

EA Page: https://en.huadongmedicine.com/companynews/Expanded-Access-Policy/

BioGate Precision Medicine Corp.

EA Page: https://www.biogate.com.tw/en

Abbvie

EA Page: https://www.abbvie.com/who-we-are/access-to-investigational-drugs-policy.html

Ethyreal Bio, Inc.

EA Page: https://www.ethyrealbio.com/expanded-access-policy/

AiCuris Anti-infective Cures AG

EA Page: https://www.aicuris.com/87/Pritelivir.htm

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Current page 46
  • Page 47
  • Page 48
  • Page 49
  • Page 50
  • Next page ››
  • Last page Last »

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA